Press release content from PR Newswire. The AP news staff was not involved in its creation.
Teijin Pharma and TransThera Biosciences Form Strategic R&D Collaboration
December 18, 2020 GMT
TOKYO and NANJING, China, Dec. 18, 2020 /PRNewswire/ Teijin Pharma Limited (“Teijin Pharma”), the core company of the Teijin Group ’s healthcare business headquartered in Tokyo, Japan, and TransThera Biosciences Co. Ltd. (“TransThera”), a clinical-stage biotechnology company based in Nanjing, China, jointly announced that they have entered into a strategic collaboration agreement for joint research and development of the innovative drugs in the target fields of oncology and inflammatory diseases.
Teijin Pharma and TransThera will establish a joint drug discovery collaboration of multiple drug targets with the immediate goal of acquiring compounds as candidates for new drug development based on the targets and compounds found by Teijin Pharma, and share the research outcomes in both J